Evidence map›Paper›PMID 24504643›Full record

ArticleIntensive care medicine2014

Noninvasive mechanical ventilation in acute respiratory failure: trends in use and outcomes.

David Schnell, Jean-François Timsit, Michael Darmon, Aurélien Vesin, Dany Goldgran-Toledano, Anne-Sylvie Dumenil, Maite Garrouste-Orgeas, Christophe Adrie, Lila Bouadma, Benjamin Planquette and 6 more

Registry-linked trialAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02731898 (Fourth International Study of Mechanical Ventilation From VENTILA GROUP), which is not on this map. Cited by 68 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 5 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02731898 unknown statusnot on this mapstarted 2020, after this paper: background citation

Fourth International Study of Mechanical Ventilation From VENTILA GROUP

TypeobservationalSponsorHospital Universitario GetafeRan2020 to 2020Enrolled3,000ConditionsAcute Respiratory Failure, Mechanical Ventilation, Critically Ill Patients, Mortality
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 5 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Gas mixture in noninvasive ventilation.Medical gas research · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 1 country.

David SchnellRéanimation médicale, Medical ICU, Hôpital Saint-Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France, david.schnell1@gmail.com.
Jean-François Timsit
Michael Darmon
Aurélien Vesin
Dany Goldgran-Toledano
Anne-Sylvie Dumenil
Maite Garrouste-Orgeas
Christophe Adrie
Lila Bouadma
Benjamin Planquette
Yves Cohen
Carole Schwebel
Lila Soufir
Samir Jamali
Bertrand Souweine
Elie Azoulay
Assistance Publique – Hôpitaux de Paris · FRInstitut pour l'avancée des biosciences · FRCentre Hospitalier de Gonesse · FRCentre Hospitalier Saint-Denis · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRHôpital André Mignot · FRHôpital Antoine-Béclère · FRHôpital Paris Saint-Joseph · FRInstitute Cancer De La Loire Lucien Neuwirth · FRUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNoninvasive ventilation (NIV) had proven benefits in clinical trials that included selected patients admitted to highly skilled centers. Whether these benefits apply to every patient and in everyday practice deserves appraisal. The aim of the study was to assess the use and outcomes of NIV over the last 15 years.

methodsMulticenter database study of critically ill patients who required ventilatory support for acute respiratory failure between 1997 and 2011. The impact of first-line NIV on 60-day mortality was evaluated using a marginal structural model. Follow-up was censored on day 60.

resultsOf 3,163 patients, 1,232 (39 %) received NIV. Over the study period, first-line NIV increased from 29 to 42 %, and NIV success rates increased from 69 to 84 %. NIV decreased 60-day mortality [adjusted hazard ratio (aHR), 0.75; 95 % confidence interval (95 % CI), 0.68-0.83; P < 0.0001]. This protective effect was observed in patients with acute-on-chronic respiratory failure (aHR, 0.71; 95 % CI, 0.57-0.90; P = 0.004), but not in patients with cardiogenic pulmonary edema (aHR, 0.85; 95 % CI, 0.70-1.03; P = 0.10) or in patients with hypoxemic ARF, either immunocompetent (aHR, 1.18; 95 % CI, 0.87-1.59; P = 0.30) or immunocompromised (aHR, 0.89; 95 % CI, 0.70-1.13; P = 0.35). NIV failure was an independent time-dependent risk factor for mortality (aHR, 4.2; 95 % CI, 2.8-6.2; P < 0.0001).

conclusionsThe use of NIV increased steadily over the study period. First-line NIV was associated with better 60-day survival and fewer ICU-acquired infections compared to first-line intubation. Survival benefits from NIV occurred only in patients with acute-on-chronic respiratory failure and immunocompromised patients.

Indexed as

Acute DiseaseAgedDatabases, FactualFemaleFollow-Up StudiesHumansMaleMiddle AgedRespiration, ArtificialRespiratory InsufficiencyTreatment FailureTreatment Outcome

Identifiers

PMID24504643
OpenAlexW2025935994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.